Work

Figure S3 from Population-based Screening for BRAFV600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis

Year: 2023

Type: other

Abstract: Kaplan-Meier estimation of overall survival of mCRC patients with BRAFV600E mutations detected by (A) IHC (BRAFIHC) and (B) NGS (BRAFNGS) demonstrates no survival difference between those with dMMR versus pMMR for BRAFIHC and BRAFNGS within individual groups.

DOI: 10.1158/1078-0432.22476708

Authors: Jenny E. Chu, Benny Johnson, Laveniya Kugathasan, Van K. Morris, Kanwal Raghav, Lucas Swanson, Howard J. Lim, Daniel J. Renouf, Sharlene Gill, Robert Wolber, Aly Karsan, Scott Kopetz, David F. Schaeffer, Jonathan M. Loree

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361815890

Cites:

Cited by:

Related to: 10